Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 635Thoracic 149Gastrointestinal 127Breast 86Dermatologic 85Genitourinary 84Gynecologic 79Sarcoma 27Other solid neoplasm 12Lymphoid 11CNS 8Endocrine 3NET 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 930Lymphoma 113Neoplasms, Plasma Cell 92Recurrence 90Lymphoma, Non-Hodgkin 69Hematologic Neoplasms 61Immunoglobulin Light-chain Amyloidosis 56Neoplasms 53Smoldering Multiple Myeloma 52Leukemia, Myeloid, Acute 51Leukemia 51Myelodysplastic Syndromes 47Leukemia, Lymphocytic, Chronic, B-Cell 44Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Hodgkin Disease 38Leukemia, Plasma Cell 27Myeloproliferative Disorders 24Breast Neoplasms 24Monoclonal Gammopathy of Undetermined Significance 23Lymphoma, Large B-Cell, Diffuse 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Amyloidosis 22Primary Myelofibrosis 21Lymphoma, Mantle-Cell 21Lymphoma, Follicular 21Ovarian Neoplasms 20Waldenstrom Macroglobulinemia 19Lymphoma, B-Cell 17Colorectal Neoplasms 17Lymphoma, B-Cell, Marginal Zone 16

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Plasma cell × 1 year × Clear all
NCT04354246 2026-05-12

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Compugen Ltd

Phase 1 Completed
94 enrolled
GastrointestinalGynecologicHead & NeckPlasma cellThoracic

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Lung Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡